Scinovex
article Open Access

Recent advancements in nasal vaccine delivery

Abstract

Mucosal administration, more especially the nasal route, is a viable and alternate method of delivering medications and vaccines. Mucosal channels are selectively used for a variety of illnesses because to their many benefits. Many attempts are currently being undertaken to create innovative nasal delivery systems and efficient medication compositions. This alternate path might help with a lot of unresolved medical problems and make long-term chronic treatments or mass vaccination campaigns easier and less expensive. Currently, the field of nasal delivery of medications and vaccinations is expanding fastly, supported by advancements in nanotechnology. It is anticipated that the number of medications authorized for nasal delivery would rise noticeably. Recently nasal vaccine against coronavirus is launched, because they provide protection exactly where it is needed. Nasal route is a effective delivery method and adjuvants being researched for the creation of nasal vaccinations are included in this review.

Advanced Drug Delivery SystemsRNA Interference and Gene DeliveryBacterial Infections and VaccinesNasal administrationMedicineVaccinationCoronavirus disease 2019 (COVID-19)Delivery systemIntensive care medicineMass vaccinationImmunologyDiseaseInfectious disease (medical specialty)
Citations
1
FWCI
0.09
field-weighted impact
References
0
Percentile
38%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Recent advancements in nasal vaccine delivery · Scinovex